rightap.blogg.se

239000011780 sodium chloride Substances 0.000 claims description 68.LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 108.229960000885 rifabutin Drugs 0.000 title claims description 61.ATEBXHFBFRCZMA-VXTBVIBXSA-N RIFABUTIN Chemical compound ATEBXHFBFRCZMA-VXTBVIBXSA-N 0.000 title claims description 61.239000000203 mixture Substances 0.000 title claims description 68.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US37166802P external-priority Application filed by Conforma Therapeutics Corp filed Critical Conforma Therapeutics Corp Priority to AU2003277299A priority Critical patent/AU2003277299B2/en Publication of AU2003226285A1 publication Critical patent/AU2003226285A1/en Application granted granted Critical Publication of AU2003226285B2 publication Critical patent/AU2003226285B2/en Anticipated expiration legal-status Critical Status Ceased legal-status Critical Current Links Original Assignee Conforma Therapeutics Corp Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Marcus Boehm Andrew Chen Edgar Ulm Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number AU2003226285A Other versions AU2003226285B2 Google Patents AU2003226285A1 - Ansamycin formulations and methods for producing and using same AU2003226285A1 - Ansamycin formulations and methods for producing and using same